fbpx Skip to main content

Member's Profile

Astex Pharmaceuticals

4420 Rosewood Dr Ste 200
Pleasanton,   California
United States
Membership Info
Membership Type: Industry
Membership Since: 2020
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Astex Pharmaceuticals
Biotech Company

Astex Pharmaceuticals (formerly SuperGen) fights for a better way to treat cancer. The company focuses on compounds in preclinical and early-stage clinical development. Its development pipeline includes candidates aiming to treat conditions such as lung cancer and leukemia. Astex Pharmaceuticals also has preclinical cancer research programs conducted in partnership with GlaxoSmithKline. Successes include cancer compound Dacogen, which is licensed to Eisai. The company, which was acquired by Otsuka Pharmaceutical in 2013, has research operations to the UK and development and regulatory operations in the US.

Related News
No related news posted by this Member